Specific phobia: A disorder of fear conditioning and extinction

CNS Spectrums

Volumn 11, Issue 4, 2006, Pages 248-251

  Stein, Dan J ^a,b   Matsunaga, Hisato ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CYCLOSERINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANXIETY DISORDER; BEHAVIOR THERAPY; CASE REPORT; COGNITION; COGNITIVE THERAPY; CONDITIONING; EVOLUTION; FEAR; FEMALE; HUMAN; MAJOR DEPRESSION; NEUROSCIENCE; PHOBIA; PRIORITY JOURNAL; PSYCHOBIOLOGY; REINFORCEMENT; REVIEW;

EID: 33646192336     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900020721     Document Type: Review

References (33)

1. LeDoux J. Fear and the brain: where have we been, and where are we going? Biol Psychiatry. 1998;44:1229-1238.
2. Davis M, Whalen PJ. The amygdala: vigilance and emotion. Mol Psychiatry. 2001;6:13-34.
3. Whalen PJ, Rauch SL, Etcoff NL, McInerney SC, Lee MB, Jenike MA. Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J Neurosci. 1998;18:411-418.
4. Whalen PJ, Kagan J, Cook RG, et al. Human amygdala responsivity to masked fearful eye whites. Science. 2004;306:2061.
5. Knight DC, Smith CN, Cheng DT, Stein EA, Helmstetter FJ. Amygdala and hippocampal activity during acquisition and extinction of human fear conditioning. Cogn Affect Behav Neurosci. 2004;4:317-325.
6. Milad MR, Rauch SL, Pitman RK, Quirk GJ. Fear extinction in rats: implications for human brain imaging and anxiety disorders. Biol Psychol. 2006 Feb 10; [Epub ahead of print].
7. Milad MR, Quinn BT, Pitman RK, et al. Thickness of ventromedial prefrontal cortex in humans is correlated with extinction memory. Proc Natl Acad Sci U S A. 2005;102:10706-10711.
8. Veltman DJ, Tuinebreijer WE, Winkelman D, et al. Neurophysiological correlates of habituation during exposure in spider phobia. Psychiatry Res. 2004;132:149-158.
9. Straube T, Mentzel HJ, Miltner WH. Neural mechanisms of automatic and direct processing of phobogenic stimuli in specific phobia. Biol Psychiatry. 2006;59:162-170.
10. Straube T, Glauer M, Dilger S, Mentzel HJ, Miltner WH. Effects of cognitive-behavioral therapy on brain activation in specific phobia. Neuroimage. 2006;29:123-135.
11. Paquette V, Levesque J, Mensour B, et al. "Change the mind and you change the brain": effects of cognitive-behavioral therapy on the neural correlates of spider phobia. Neuroimage. 2003;18:401-409.
12. Mei B, Li C, Dong S, Jiang CH, Wang H, Hu Y. Distinct gene expression profiles in hippocampus and amygdala after fear conditioning. Brain Res Bull. 2005;67:1-12.
13. Kendler KS, Neale MC, Kessler RC, et al. The genetic epidemiology of phobias in women. The interrelationship of agoraphobia, social phobia, situational phobia, and simple phobia. Arch Gen Psychiatry. 1992;49:273-281.
14. Rachman S, Seligman ME. Unprepared phobias: "be prepared". Behav Res Ther. 2002;40:127-129.
15. Poulton R, Menzies RG. Non-associative fear acquisition: a review of the evidence from retrospective and longitudinal research. Behav Res Ther. 2002;40:127-149.
16. Smoller JW, Yamaki LH, Fagerness JA, et al. The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder. Biol Psychiatry. 2005;57:1485-1492.
17. Somerville LH, Kim H, Johnstone T, et al. Human amygdala responses during presentation of happy and neutral faces: correlations with state anxiety. Biol Psychiatry. 2004;55:897-903.
18. Hariri AR, Mattay VS, Tessitore A, et al. Serotonin transporter genetic variation and the response of the human amygdala. Science. 2002;297:400-403.
19. Pezawas L, Meyer-Lindenberg A, Drabant EM, et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci. 2005;8:828-834.
20. Brown SM, Peet E, Manuck SB, et al. A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol Psychiatry. 2005;10:884-888.
21. Bertolino A, Arciero G, Rubino V, et al. Variation of human amygdala response during threatening stimuli as a function of 5'HTTLPR genotype and personality style. Biol Psychiatry. 2005;57:1517-1525.
22. Hofer MA. Unexplained infant crying: an evolutionary perspective. Acta Paediatr. 2002;91:491-496.
23. Marks IM, Nesse RM. Fears and fitness an evolutionary analysis of anxiety disorders. Ethol Sociobiol. 1994;15:247-261.
24. Nesse RM. The smoke detector principle. Natural selection and the regulation of defensive responses. Ann N Y Acad Sci. 2001;935:75-85.
25. Stein DJ, Bouwer C. A neuro-evolutionary approach to the anxiety disorders. J Anxiety Disord. 1997;11:409-429.
26. Veit R, Flor H, Erb M, et al. Brain circuits involved in emotional learning in antisocial behavior and social phobia in humans. Neurosci Lett. 2002;328:233-236.
27. Menzies RG, Harris LM. Mode of onset in evolutionary-relevent and evolutionary-neutral phobias: evidence from a clinical sample. Depress Anxiety. 1997;5:134-136.
28. Vythilingum B, Stein DJ. Specific phobia. In: Stein DJ, ed. Clinical Manual of Anxiety Disorders. Washington, DC: American Psychiatric Publishing; 2004:.
29. Marks IM, Mathews AM. Brief standard self-rating for phobic patients. Behav Res Ther. 1979;17:263-267.
30. Cohen DC. Comparison of self-report and overt behavioral procedures for assessing acrophobia. Behav Ther. 1977;8:17-23.
31. Maj M, Akiskal HS, Lopex-Ibor JJ, Okasha A. Phobias. New York, NY: John Wiley; 2004.
32. Benjamin J, Ben-Zion IZ, Karbofsky E, Dannon P. Double-blind placebo-controlled pilot study of paroxetine for specific phobia. Psychopharmacology. 2000;149:194-196.
33. Ressler KJ, Rothbaum BO, Tannenbaum L, et al. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry. 2004;61:1136-1144.